New vaccine tested to arm immune systems against common virus in people with HIV
NCT ID NCT05099965
Summary
This study tested a vaccine designed to strengthen the immune system's response to cytomegalovirus (CMV) in adults who have both HIV and CMV. 90 participants, all with well-controlled HIV on stable medication, received either two doses of the experimental vaccine or a placebo. The main goals were to check the vaccine's safety and see if it successfully boosted the body's immune cells that fight CMV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alabama CRS
Birmingham, Alabama, 35222, United States
-
Case Clinical Research Site
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS
Chapel Hill, North Carolina, 27599, United States
-
Houston AIDS Research Team CRS
Houston, Texas, 77009, United States
-
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, 02114, United States
-
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, 19104, United States
-
UCLA CARE Center CRS
Los Angeles, California, 90035-4709, United States
-
UCSD Antiviral Research Center
San Diego, California, 92103, United States
-
Ucsf Hiv/Aids Crs
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS
Aurora, Colorado, 80045, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
-
Washington University Therapeutics (WT) CRS
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.